| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 164.66▲ | 167.07▼ | 167.52▼ | 205.17▼ | 214.65▼ |
| MA10 | 165.02▼ | 168.48▼ | 170.51▼ | 216.63▼ | 232.07▼ |
| MA20 | 166.07▼ | 171.89▼ | 190.81▼ | 221.64▼ | 246.53▼ |
| MA50 | 168.33▼ | 200.22▼ | 212.23▼ | 236.50▼ | 304.47▼ |
| MA100 | 171.22▼ | 213.54▼ | 220.97▼ | 252.12▼ | 316.51▼ |
| MA200 | 188.12▼ | 221.85▼ | 229.38▼ | 285.48▼ | 258.44▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.015▼ | 1.036▲ | -1.550▼ | -5.276▼ | -2.576▼ |
| RSI | 35.654▼ | 21.862▼ | 12.967▼ | 22.051▼ | 29.547▼ |
| STOCH | 31.762 | 13.920▼ | 7.210▼ | 24.332 | 26.156 |
| WILL %R | -62.592 | -90.805▼ | -96.070▼ | -97.753▼ | -98.665▼ |
| CCI | -63.778 | -146.546▼ | -109.826▼ | -267.734▼ | -268.548▼ |
|
Thursday, October 29, 2026 10:01 AM
Alnylam Pharmaceuticals (NASDAQ:ALNY) reported third-quarter 2026 global net product revenue of approximately $1.3 billion, up 52% from a year earlier and 10% sequentially, as growth in its ...
|
|
Thursday, October 29, 2026 09:04 AM
Key TakeawaysAlnylam shares fell 19% after it expanded its nucresiran heart trial for the second time this year, despite 52% growth in product revenue. Sizing the trial for fewer cardiovascular events ...
|
|
Thursday, October 29, 2026 07:29 AM
Stifel analyst Paul Matteis downgraded Alnylam Pharmaceuticals (NASDAQ: ALNY) from Buy to Hold with a price target of $225.00 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/10/26 | 172.695 | 180.6118 | 163.30 | 165.00 | 6,997,252 |
| 29/10/26 | 185.59 | 202.37 | 172.31 | 174.00 | 11,795,551 |
| 28/10/26 | 222.72 | 232.88 | 220.00 | 232.40 | 1,892,156 |
| 27/10/26 | 225.00 | 228.49 | 222.82 | 226.79 | 1,603,180 |
| 26/10/26 | 226.24 | 232.48 | 224.1001 | 227.66 | 1,433,471 |
| 23/10/26 | 227.28 | 229.39 | 222.00 | 224.03 | 1,055,926 |
| 22/10/26 | 224.92 | 229.82 | 223.76 | 227.28 | 2,211,894 |
| 21/10/26 | 227.86 | 230.84 | 224.88 | 225.10 | 1,177,338 |
| 20/10/26 | 237.73 | 238.96 | 229.54 | 230.71 | 1,457,897 |
| 19/10/26 | 232.645 | 236.54 | 231.255 | 233.29 | 1,344,097 |
|
|
||||
|
|
||||
|
|